HPS-124 - Analysis of rationality of drug prescription of dihydroergotamine

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-124
• By: LI, Min-fen (Department Of Pharmacy, E-da Hospital, China Taiwan)
• Co-author(s): Ms Min-fen Li (Department Of Pharmacy, E-da Hospital, Kaohsiung, China Taiwan)
  Mr. Yung-Chia Hsu (Department Of Pharmacy, E-da Hospital, Kaohsiung, China Taiwan)
  
• Abstract:

  Introduction
  The Taiwan Food and Drug Administration (TFDA) has issued warnings regarding ergot derivatives due to their potential to increase the risk of fibrosis—an excessive formation of connective tissue that may damage organs and bodily structures—and symptoms of ergot poisoning, such as spasms and impaired blood circulation. The TFDA has ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login